Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

MAHA advocates are skeptical of President Donald Trump's deal to lower drug prices for GLP-1 anti-obesity drugs.

President Donald Trump promises lower prices for weight loss drugs and reveals, one of his key staff members has a ...

CMS launches pilot to lower Medicaid drug costs by aligning prices with other developed countries, starting January 2026 to reduce state and ...

A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist ...

GLP-1s are about to get more affordable in the United States, thanks to a new deal announced Thursday, Nov. 6 by the Trump ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

It appears that President Donald Trump’s angry social media posts have once again landed him in hot water in the courts: A ...

Eli Lilly and Novo Nordisk will lower prices for GLP-1 drugs, aligning with new drug pricing initiatives and Medicare Part D pilot coverage starting April 2026. Lilly's Zepbound and orforglipron will ...

The list prices of obesity drugs Wegovy and Zepbound are over $1,000, but that's not necessarily what you pay.

Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available ...

A White House guest collapsed behind President Trump during an Oval Office press conference, leading to an abrupt pause in ...